IA
VIVO

IFP Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

IFP Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17
Closed -$3K – 4912
2022
Q3 		$3K Sell
17
-4
-19% -$130 ﹤0.01% 4296
2022
Q2 		$3K Hold
21
– – ﹤0.01% 4059
2022
Q1 		$3K Buy
+21
New +$500 ﹤0.01% 4059
2019
Q4 		– Sell
-2,200
Closed -$20.7K – 3199
2019
Q3 		$21K Buy
+2,200
New +$23.2K ﹤0.01% 1745
2017
Q4 		– Sell
-2,117
Closed -$30K – 4188
2017
Q3 		$30K Buy
2,117
+15
+0.7% +$214 ﹤0.01% 2346
2017
Q2 		$33K Buy
2,102
+15
+0.7% +$216 ﹤0.01% 2262
2017
Q1 		$29K Buy
2,087
+1,378
+194% +$19.3K ﹤0.01% 2269
2016
Q4 		$13K Sell
709
-457
-39% -$8.03K ﹤0.01% 2769
2016
Q3 		$22K Sell
1,166
-23
-2% -$450 ﹤0.01% 2360
2016
Q2 		$23K Buy
+1,189
New +$23.3K ﹤0.01% 2272
2016
Q1 		– Sell
-890
Closed -$18K – 3631
2015
Q4 		$18K Buy
+890
New +$17.1K ﹤0.01% 2233

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFP Advisors's VIVO Position: Q4 2022 in Review

IFP Advisors sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 17 shares — an estimated $3K sold.

IFP Advisors first reported a position in VIVO in Q4 2015 and held it in 11 quarters. The position peaked at $33K in Q2 2017. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • IFP Advisors reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
  • IFP Advisors sold 17 Meridian Bioscience Inc shares in Q4 2022, an estimated $3K.
  • IFP Advisors first reported a position in Meridian Bioscience Inc in Q4 2015 and held it in 11 quarters.
  • IFP Advisors's Meridian Bioscience Inc position peaked at $33K in Q2 2017.
  • 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.